1nd International Virtual Congress on Dementia and Alzheimer's Diseases (DAC), 2024, Peptidylglycine α-amidating monooxygenase as a novel biomarker target for diagnosis and therapy of neurological degenerative conditions

Goetze et al. 2023, Peptidylglycine α-amidating monooxygenase and adrenomedullin measurement in patients with hepatic cirrhosis

Ilina et al. 2023, Immunoassay-based quantification of full-length peptidylglycine alpha-amidating monooxygenase in human plasma

Alzheimer's & Parkinson's Diseases Conference (AD/PD) 2022, "Disrupted adrenomedullin homeostasis as a predictive biomarker for Alzheimer´s disease"

Kaufmann et al. 2021, Novel insights into peptide amidation and amidating activity in the human circulation

The Lancet Summit, 2021: Presymptomatic Prevention and Treatment of Neurodegenerative Diseases